Hangzhou Tigermed Consulting Co (HKSE:03347) Tax Provision: HK$-250 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:03347 Hangzhou Tigermed Consulting Co Ltd HKSE:03347
92 GF Score
Price HK$41.40
GF Value HK$45.33
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Hangzhou Tigermed Consulting Co Tax Provision?

Hangzhou Tigermed Consulting Co HKSE:03347 -1.24% 92 Tax Provision is HK$-250 Mil as of Jun. 2026. GuruFocus rates HKSE:03347 with a GF Score™ of 92/100 and a GF Value™ of HK$45.33 (Fairly Valued). The stock has 6 warning signs investors should review.

Hangzhou Tigermed Consulting Co's tax provision for the three months ended in Jun. 2026 was HK$-34 Mil. Its tax provision for the trailing twelve months (TTM) ended in Jun. 2026 was HK$-250 Mil.

Hangzhou Tigermed Consulting Co Tax Provision Historical Data

* Premium members only.

The historical data trend for Hangzhou Tigermed Consulting Co's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Tigermed Consulting Co Tax Provision Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only -358.60 -350.26 -370.36 -231.29 -218.91

Hangzhou Tigermed Consulting Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -50.52 -56.00 -74.08 -86.15 -34.00
HKSE:03347
92GF Score
Hangzhou Tigermed Consulting Co Ltd HKSE:03347
Tax Provision is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hangzhou Tigermed Consulting Co Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-250 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of HK$-250 Mil mean?
Hangzhou Tigermed Consulting Co (HKSE:03347) has a Tax Provision of HK$-250 Mil as of Jun. 2026. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Hangzhou Tigermed Consulting Co and its competitors.
Is Hangzhou Tigermed Consulting Co's Tax Provision too high?
Hangzhou Tigermed Consulting Co's current Tax Provision is HK$-250 Mil. Overall, Hangzhou Tigermed Consulting Co has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Tigermed Consulting Co's Tax Provision compare to TMO and DHR?
Hangzhou Tigermed Consulting Co's Tax Provision of HK$-250 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Medical Diagnostics & Research company?
A good Tax Provision depends on the Medical Diagnostics & Research industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Hangzhou Tigermed Consulting Co and its competitors. Hangzhou Tigermed Consulting Co's current Tax Provision is HK$-250 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Tigermed Consulting Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou Tigermed Consulting Co (HKSE:03347) is currently considered Fairly Valued. The stock's GF Value™ is HK$45.33, compared to a current price of HK$41.40 — trading 8.7% below its estimated fair value. The current Tax Provision is HK$-250 Mil. Hangzhou Tigermed Consulting Co's overall GF Score™ is 92/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For Hangzhou Tigermed Consulting Co (HKSE:03347), the current Tax Provision is HK$-250 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hangzhou Tigermed Consulting Co (HKSE:03347) Overvalued in 2026?

Based on GuruFocus' analysis, Hangzhou Tigermed Consulting Co stock appears to be undervalued. The current stock price of HK$41.40 is trading 8.7% below its estimated GF Value™ of HK$45.33. GuruFocus considers Hangzhou Tigermed Consulting Co to be Fairly Valued.

Key valuation signals for HKSE:03347:

  • Tax Provision: HK$-250 Mil
  • GF Value™: HK$45.33 vs. price of HK$41.40 (8.7% below fair value)
  • GF Score™: 92/100 with 6 warning signs

No single metric tells the full story. See the HKSE:03347 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hangzhou Tigermed Consulting Co Business Description

Other Exchanges 5HZ1:Germany300347:China
Address No. 508 Lujiatan Street, Room 601-610, 6th Floor, Puyan Sub-District, Binjiang District, Zhejiang Province, Hangzhou, CHN
Hangzhou Tigermed Consulting Co Ltd is a China-based provider of comprehensive biopharmaceutical R&D services, with an expanding world-wide presence. The Group is principally engaged in CRO services.
92GF Score

Get the complete analysis for HKSE:03347

Tax Provision is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$41.40
Price
HK$45.33
GF Value